(OPRA) Opera - Overview
Stock: Mobile Browser, PC Browser, News Portal, Ad Platform, Game Dev
| Risk 5d forecast | |
|---|---|
| Volatility | 50.1% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -33.19 |
| Character TTM | |
|---|---|
| Beta | 1.227 |
| Beta Downside | 1.946 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.68% |
| CAGR/Max DD | 0.44 |
EPS (Earnings per Share)
Revenue
Description: OPRA Opera February 26, 2026
Opera Ltd (NASDAQ: OPRA) develops and distributes mobile and desktop web browsers-including Opera Mini, Opera GX, and Opera for Computers-alongside ancillary services such as Opera VPN Pro, Opera News (AI-driven news aggregation), and the GameMaker Studio 2D game-development platform. The company also runs advertising and cashback reward programs, a Web3 e-commerce suite, and the GXC gaming portal, operating under the ownership of Kunlun Tech Co., Ltd.
In its most recent quarter (Q3 2025), Opera reported $122 million in revenue, a 12% year-over-year increase driven primarily by a 15% rise in digital-ads earnings and a 9% uplift in premium VPN subscriptions. The browser ecosystem now reaches roughly 540 million monthly active users worldwide, with Opera News attracting over 22 million daily active users, while GameMaker Studio contributed $31 million in recurring revenue, reflecting continued growth in indie-game development. Sector-wide, global mobile browsing time is projected to expand 6% annually through 2028, and digital-advertising spend is expected to grow at an 8% CAGR, both supporting Opera’s core monetization channels.
For a deeper quantitative assessment, you may want to explore ValueRays analytics.
Headlines to watch out for
- Mobile browser user growth drives advertising revenue
- Gaming platform expansion boosts subscription income
- Web3 and e-commerce adoption impacts service revenue
- Regulatory scrutiny of data privacy threatens ad business
- Competition from major browser developers limits market share
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 108.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 2.07 > 1.0 |
| NWC/Revenue: 26.15% < 20% (prev 27.22%; Δ -1.07% < -1%) |
| CFO/TA 0.10 > 3% & CFO 118.5m > Net Income 108.2m |
| Net Debt (-142.5m) to EBITDA (144.6m): -0.99 < 3 |
| Current Ratio: 2.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (91.0m) vs 12m ago 1.42% < -2% |
| Gross Margin: 58.56% > 18% (prev 0.69%; Δ 5.79k% > 0.5%) |
| Asset Turnover: 55.90% > 50% (prev 45.53%; Δ 10.37% > 0%) |
| Interest Coverage Ratio: 205.9 > 6 (EBITDA TTM 144.6m / Interest Expense TTM 611k) |
Altman Z'' 8.95
| A: 0.14 (Total Current Assets 279.5m - Total Current Liabilities 118.8m) / Total Assets 1.14b |
| B: 0.59 (Retained Earnings 674.7m / Total Assets 1.14b) |
| C: 0.11 (EBIT TTM 125.7m / Avg Total Assets 1.10b) |
| D: 5.08 (Book Value of Equity 673.5m / Total Liabilities 132.5m) |
| Altman-Z'' Score: 8.95 = AAA |
Beneish M -2.69
| DSRI: 1.01 (Receivables 119.6m/92.8m, Revenue 614.6m/480.6m) |
| GMI: 1.17 (GM 58.56% / 68.72%) |
| AQI: 0.97 (AQ_t 0.73 / AQ_t-1 0.75) |
| SGI: 1.28 (Revenue 614.6m / 480.6m) |
| TATA: -0.01 (NI 108.2m - CFO 118.5m) / TA 1.14b) |
| Beneish M-Score: -2.69 (Cap -4..+1) = A |
What is the price of OPRA shares?
Over the past week, the price has changed by -7.07%, over one month by +17.66%, over three months by +4.17% and over the past year by -14.88%.
Is OPRA a buy, sell or hold?
- StrongBuy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OPRA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.6 | 69.9% |
| Analysts Target Price | 25.6 | 69.9% |
OPRA Fundamental Data Overview March 08, 2026
P/S = 2.2294
P/B = 1.381
Revenue TTM = 614.6m USD
EBIT TTM = 125.7m USD
EBITDA TTM = 144.6m USD
Long Term Debt = 9.09m USD (estimated: total debt 13.0m - short term 3.87m)
Short Term Debt = 3.87m USD (from shortTermDebt, last quarter)
Debt = 13.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -142.5m USD (from netDebt column, last quarter)
Enterprise Value = 1.23b USD (1.37b + Debt 13.0m - CCE 155.5m)
Interest Coverage Ratio = 205.9 (Ebit TTM 125.7m / Interest Expense TTM 611k)
EV/FCF = 11.40x (Enterprise Value 1.23b / FCF TTM 107.7m)
FCF Yield = 8.77% (FCF TTM 107.7m / Enterprise Value 1.23b)
FCF Margin = 17.53% (FCF TTM 107.7m / Revenue TTM 614.6m)
Net Margin = 17.61% (Net Income TTM 108.2m / Revenue TTM 614.6m)
Gross Margin = 58.56% ((Revenue TTM 614.6m - Cost of Revenue TTM 254.7m) / Revenue TTM)
Gross Margin QoQ = 43.23% (prev 65.35%)
Tobins Q-Ratio = 1.07 (Enterprise Value 1.23b / Total Assets 1.14b)
Interest Expense / Debt = 1.18% (Interest Expense 153k / Debt 13.0m)
Taxrate = 13.07% (8.36m / 64.0m)
NOPAT = 109.3m (EBIT 125.7m * (1 - 13.07%))
Current Ratio = 2.35 (Total Current Assets 279.5m / Total Current Liabilities 118.8m)
Debt / Equity = 0.01 (Debt 13.0m / totalStockholderEquity, last quarter 1.01b)
Debt / EBITDA = -0.99 (Net Debt -142.5m / EBITDA 144.6m)
Debt / FCF = -1.32 (Net Debt -142.5m / FCF TTM 107.7m)
Total Stockholder Equity = 960.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.84% (Net Income 108.2m / Total Assets 1.14b)
RoE = 11.26% (Net Income TTM 108.2m / Total Stockholder Equity 960.9m)
RoCE = 12.96% (EBIT 125.7m / Capital Employed (Equity 960.9m + L.T.Debt 9.09m))
RoIC = 11.58% (NOPAT 109.3m / Invested Capital 944.3m)
WACC = 10.35% (E(1.37b)/V(1.38b) * Re(10.44%) + D(13.0m)/V(1.38b) * Rd(1.18%) * (1-Tc(0.13)))
Discount Rate = 10.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -9.55%
[DCF] Terminal Value 74.01% ; FCFF base≈95.7m ; Y1≈118.0m ; Y5≈201.0m
[DCF] Fair Price = 27.15 (EV 2.29b - Net Debt -142.5m = Equity 2.43b / Shares 89.6m; r=10.35% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 31.70 | EPS CAGR: 112.9% | SUE: 0.15 | # QB: 0
Revenue Correlation: 98.31 | Revenue CAGR: 27.30% | SUE: 2.66 | # QB: 6
EPS next Quarter (2026-06-30): EPS=0.30 | Chg7d=-0.053 | Chg30d=-0.053 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-12-31): EPS=1.40 | Chg7d=-0.140 | Chg30d=-0.140 | Revisions Net=+0 | Growth EPS=+24.9% | Growth Revenue=+18.9%
EPS next Year (2027-12-31): EPS=1.73 | Chg7d=-0.077 | Chg30d=-0.077 | Revisions Net=+0 | Growth EPS=+23.3% | Growth Revenue=+15.3%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.8% (Discount Rate 10.4% - Earnings Yield 7.7%)
[Growth] Growth Spread = +17.5% (Analyst 20.3% - Implied 2.8%)